Are hEDS, POTS, MCAS, and CCI Related? Understanding the Overlap

When hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and craniocervical instability (CCI) appear in the same patient, it can be tempting to treat them as four pieces of one disorder. These conditions can overlap, but they are not one diagnosis, and the strength of evidence connecting them varies considerably.

These are separate diagnoses involving different physiological systems. They can coexist, share symptoms, and potentially influence one another, but the scientific evidence is not equally strong for every proposed connection.

Understanding that distinction matters because accurate diagnosis, and effective treatment, depends on identifying which systems are actually involved rather than attributing every symptom to one condition.

What Is the Connection Between hEDS, POTS, MCAS, and CCI?

The short answer is that hEDS, POTS, MCAS, and CCI are four distinct diagnoses that are frequently reported together in the same patients, particularly in specialty hypermobility clinics. Some of these connections, like hEDS and orthostatic intolerance, are supported by meaningful clinical research. Others, like hEDS and MCAS, or CCI and systemic autonomic dysfunction, remain association rather than established cause and effect. Sorting out which relationship applies to a given patient is what makes evaluation and treatment genuinely individualized rather than a single protocol applied to four labels at once.

How Hypermobile EDS Can Affect Multiple Body Systems

Hypermobile Ehlers-Danlos syndrome is a heritable connective-tissue disorder diagnosed clinically. It is characterized by generalized joint hypermobility along with additional systemic and musculoskeletal features. Unlike most other EDS subtypes, a single causative genetic marker for hEDS has not yet been established, so current diagnosis relies on clinical criteria.

Connective tissue contributes to the mechanical properties of joints, skin, blood vessels, and many supporting structures throughout the body. In hEDS, joint instability and impaired proprioception, among other hypermobile EDS symptoms, can increase the muscular work required to stabilize the body. Patients may experience pain, fatigue, recurrent joint injury, and reduced activity tolerance.

Why hEDS and POTS Commonly Occur Together

This structural vulnerability may also intersect with autonomic symptoms. Dysautonomia and orthostatic intolerance are frequently reported in hEDS populations, and studies have documented a meaningful clinical association between hEDS and POTS. In one study of people with POTS, 31 percent met the 2017 clinical criteria for hEDS, while another 24 percent had generalized joint hypermobility without meeting full hEDS criteria. However, association does not prove that abnormal connective tissue directly causes POTS in every patient.

Postural orthostatic tachycardia syndrome is a chronic disorder of orthostatic intolerance. Current diagnostic criteria generally require a sustained heart-rate increase of at least 30 beats per minute in adults, or at least 40 beats per minute in adolescents ages 12 to 19, within 10 minutes of standing, without significant orthostatic hypotension. Symptoms must be chronic, typically present for at least three months, and other explanations for sinus tachycardia must be excluded.

The tachycardia is therefore not the entire disorder. It is often part of the body’s attempt to maintain adequate circulation while upright.

POTS is heterogeneous. Potential contributors can include reduced circulating blood volume, impaired peripheral vasoconstriction, excessive sympathetic activation, autonomic neuropathy, deconditioning, and other mechanisms.

Clinicians sometimes describe these as overlapping neuropathic, hyperadrenergic, and hypovolemic POTS subtypes, though a given patient may show features of more than one. Different patients may have different combinations, which is part of why neurogenic POTS and other proposed subtypes are discussed separately in the literature rather than treated as one uniform presentation.

One proposed link between hEDS and POTS is increased vascular compliance. If veins do not maintain vascular tone efficiently when a person stands, more POTS and blood pooling may occur in the legs and abdomen, reducing venous return, cardiac filling, and stroke volume. The body may compensate by increasing heart rate and sympathetic nervous-system activity. This is biologically plausible, but it should not be presented as the proven mechanism of POTS in every person with hEDS. The underlying pathophysiology is likely multifactorial.

Can Small-Fiber Dysfunction Contribute to POTS?

Another possible connection involves small-fiber neuropathy. Small nerve fibers transmit pain and temperature information, but autonomic small fibers also participate in sweating and regulation of blood-vessel tone.

Studies have identified small-fiber abnormalities in some patients with EDS and hEDS/HSD. If autonomic fibers are affected, peripheral blood vessels may not constrict normally during upright posture, potentially contributing to a neuropathic POTS phenotype. Importantly, this does not mean that everyone with hEDS has small-fiber neuropathy, nor does the presence of neuropathic symptoms establish the diagnosis without appropriate testing.

What Is MCAS and How Does It Relate to POTS?

Mast cell activation syndrome is also frequently discussed alongside hEDS and POTS, but MCAS is a specific clinical diagnosis, not simply a collection of food reactions, flushing, itching, or unexplained symptoms.

Mast cells can release numerous inflammatory mediators, including histamine, tryptase, prostaglandins, leukotrienes, cytokines, and chemokines. These mediators can affect the skin, gastrointestinal tract, cardiovascular system, and airways.

Widely cited consensus criteria for MCAS require recurrent systemic episodes consistent with mast-cell activation, objective evidence of increased mast-cell mediator release, and clinical improvement with appropriate mediator-targeted treatment. For tryptase, a commonly used biochemical standard is an event-related rise above baseline of 20 percent plus 2 ng/mL.

This distinction is important because many symptoms associated with MCAS overlap with allergy, migraine, gastrointestinal disorders, medication effects, dysautonomia, and other conditions. Improvement after taking an antihistamine alone is not enough to establish MCAS.

Mast-cell mediators can cause vasodilation and increase vascular permeability. During an activation episode, these effects may alter vascular tone or effective circulating volume and may contribute to tachycardia or blood-pressure instability. A mast-cell-associated hyperadrenergic POTS phenotype has been described in the literature, particularly in patients with episodic flushing and other systemic symptoms. This represents a subset, not a universal explanation for POTS.

Is MCAS Actually Associated With hEDS?

The proposed hEDS-MCAS relationship is even less settled than the hEDS-POTS relationship. These diagnoses are frequently reported together in specialty populations, but prevalence estimates vary substantially depending on how MCAS is defined. Current evidence does not establish that altered connective tissue directly causes MCAS or that MCAS causes hEDS. The association deserves further investigation, but it should not be presented as proven causation.

What Is Craniocervical Instability in EDS?

Craniocervical instability refers to pathological instability at the junction between the skull and upper cervical spine. Atlantoaxial instability, or AAI, is related but specifically involves instability between C1 and C2. This falls within the broader topic of craniocervical instability as it presents in connective-tissue disorders.

In connective-tissue disorders, ligamentous laxity may theoretically reduce passive stability at these regions. When clinically significant instability is present, selected patients may report severe occipital or upper-cervical pain, a heavy-head sensation, symptoms related to neck position, and neurological complaints. These symptoms are not specific to CCI, however, and require careful differential diagnosis.

Radiographic measurements discussed in the CCI literature include the clivo-axial angle, Harris measurement, Grabb-Mapstone-Oakes measurement, and measures of C1-C2 angular displacement. A systematic review of CCI in EDS emphasized that the available evidence remains limited and that surgical treatment should be considered only when clear radiographic instability corresponds with compatible symptoms and neurological findings.

That point is particularly important in medically complex patients. An abnormal imaging measurement by itself does not automatically establish symptomatic CCI.

Can Craniocervical Instability Cause POTS?

This is one of the most interesting, and least settled, parts of the discussion.

It is biologically plausible that severe pathology at the craniocervical junction could influence autonomic function in selected patients through mechanical effects involving the brainstem, upper spinal cord, autonomic pathways, or related sensory input. Retrospective surgical studies have reported improvements in some autonomic and orthostatic symptoms after craniocervical stabilization in carefully selected EDS patients.

However, these studies involve highly selected populations, are not randomized controlled trials, and cannot prove that CCI directly caused POTS. The broader literature continues to note a lack of high-quality prospective evidence regarding CCI evaluation and treatment in EDS. At this stage, the CCI-POTS relationship should be described as emerging science rather than an established cause-and-effect pathway.

How hEDS, POTS, MCAS, and CCI Compare

The table below summarizes the primary system involved, key features, and current strength of evidence connecting each condition back to hEDS.

Condition	Primary System	Key Features	Relationship to hEDS
hEDS	Connective tissue	Hypermobility, instability, pain	Primary condition
POTS	Autonomic / circulatory	Orthostatic intolerance, tachycardia	Strong clinical association
MCAS	Immune / mast cell	Episodic mediator-related symptoms	Relationship remains debated
CCI	Craniocervical / neurological	Mechanical instability with compatible symptoms	Associated in selected patients

How hEDS, POTS, MCAS, and CCI Symptoms Can Overlap

Even when one diagnosis does not directly cause another, several disorders can interact functionally.

A patient with hEDS may expend more muscular effort maintaining joint and postural stability. POTS may reduce upright tolerance and increase sympathetic demand. A mast-cell activation episode may temporarily alter vascular tone or fluid balance. Clinically significant CCI, when present, may add mechanical pain or neurological stress.

Then common stressors, such as heat, dehydration, infection, poor sleep, hormonal changes, pain, prolonged standing, or overexertion, may aggravate several systems at once. This can make the conditions feel like one interconnected illness even when the underlying diagnoses remain distinct.

Why Treatment Must Be Individualized

Treatment should follow the mechanism and diagnosis actually present. Suspected MCAS warrants appropriate allergy/immunology evaluation and mediator-directed treatment. Suspected CCI requires neurological assessment and specialist evaluation, with imaging interpreted in the context of the clinical examination. POTS and hEDS management, covered in more detail below, follow the same principle: the approach depends on which system is driving the symptom.

This is especially important because an intervention appropriate for one patient may be inappropriate for another. Increasing fluid or sodium intake, for example, may not be suitable for certain cardiac, renal, or blood-pressure conditions. Likewise, forceful cervical treatment should be avoided when significant instability is suspected until the patient has been appropriately evaluated.

What This Overlap Means for Physical Therapy

For a physical therapist, a patient presenting with hEDS, POTS, MCAS, and possible CCI is not a single treatment plan applied four times over. It is a reason to ask which system is driving which symptom on a given day, and to sequence care accordingly. physical therapy for hypermobile EDS typically begins with low-load, symptom-contingent joint stabilization work. Where orthostatic intolerance is present, physical therapy for dysautonomia may include hydration, sodium when medically appropriate, compression, and carefully prescribed physical conditioning, with exercise position and progression adjusted around POTS rehabilitation principles rather than a standard strengthening template. Where mast-cell symptoms are active, session intensity and timing may need to flex around the patient’s current tolerance. Where CCI is suspected or confirmed, manual therapy and loading decisions at the cervical spine require specific caution and close coordination with the treating specialist.

The Bottom Line: Connected Does Not Mean Identical

Complex symptoms deserve validation without sacrificing scientific precision.

The goal is not to force every symptom into a single diagnosis. It is to ask which systems are involved, which diagnostic criteria are actually met, which proposed mechanisms are supported by evidence, and which treatments are appropriate for this individual. Because interconnected does not mean identical, and medically complex does not mean imaginary.

If you are navigating hEDS, POTS, MCAS, or CCI, and no one has looked at how your systems interact rather than treating each diagnosis in isolation, that is exactly the kind of evaluation we specialize in. Talk to one of our EDS-informed specialists. The first conversation is free.

Frequently Asked Questions

Are hEDS, POTS, MCAS, and craniocervical instability related?

They are frequently reported together in the same patients, particularly in specialty hypermobility clinics, but they are separate diagnoses. The strength of evidence connecting them varies: hEDS and orthostatic intolerance have a well-documented clinical association, while the hEDS-MCAS and CCI-autonomic dysfunction relationships remain less established.

Can hypermobile Ehlers-Danlos syndrome cause POTS?

Current evidence supports an association rather than proven causation. Proposed mechanisms include increased vascular compliance and small-fiber autonomic nerve involvement, but the underlying pathophysiology of POTS in hEDS is likely multifactorial and not fully explained by any single mechanism.

Why are POTS and hEDS commonly diagnosed together?

Studies have found that a substantial proportion of people with POTS also meet clinical criteria for hEDS or have generalized joint hypermobility, suggesting shared physiological vulnerability, most plausibly related to connective tissue effects on vascular tone and autonomic nerve function.

Is MCAS associated with hypermobile Ehlers-Danlos syndrome?

The two are frequently reported together in specialty populations, but current evidence does not establish that altered connective tissue causes MCAS or that MCAS causes hEDS. The relationship remains debated and prevalence estimates vary depending on how MCAS is defined.

Can MCAS make POTS symptoms worse?

In a subset of patients, mast-cell mediators can alter vascular tone or effective circulating volume during an activation episode, potentially contributing to tachycardia or blood-pressure instability. This describes a specific phenotype, not a universal explanation for POTS.

Can hEDS cause craniocervical instability?

Ligamentous laxity in connective-tissue disorders may theoretically reduce passive stability at the craniocervical junction. Evidence in this area remains limited, and an abnormal imaging measurement alone does not establish symptomatic CCI.

Can craniocervical instability cause POTS?

This remains an emerging, unsettled area. Some retrospective surgical studies report improved autonomic symptoms after craniocervical stabilization in carefully selected patients, but these are not randomized trials and cannot prove that CCI directly causes POTS.

How is craniocervical instability diagnosed in EDS?

Diagnosis relies on a combination of clinical symptoms, neurological findings, and radiographic measurements such as the clivo-axial angle or C1-C2 angular displacement, interpreted together rather than from imaging alone.

Can physical therapy help people with hEDS and POTS?

Yes, when the approach is individualized. This typically means joint stabilization and proprioceptive training for hEDS combined with position, pacing, and progression adjustments specific to orthostatic intolerance for POTS, rather than a single generic exercise program.

Why is it important to distinguish association from causation in hEDS, POTS, MCAS, and CCI?

Treating every overlapping diagnosis as one unified disorder risks both overtreatment and undertreatment. Distinguishing established associations from proposed mechanisms and emerging hypotheses allows treatment to target the systems that are actually involved in a given patient.

This article is for educational purposes and does not replace individualized medical evaluation. hEDS, POTS, MCAS, and craniocervical instability are distinct diagnoses, and the presence of one does not confirm the presence of another. Anyone with symptoms suggestive of these conditions should be evaluated by an appropriate specialist.